BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $894,418 | -28.1% | 17,810 | -9.6% | 0.05% | -24.6% |
| Q2 2023 | $1,244,661 | +36.1% | 19,694 | -3.1% | 0.06% | +32.6% |
| Q1 2023 | $914,692 | -2.8% | 20,331 | -5.4% | 0.05% | -6.1% |
| Q4 2022 | $941,477 | +13.0% | 21,490 | +70.0% | 0.05% | +4.3% |
| Q3 2022 | $833,000 | +30.0% | 12,644 | -0.3% | 0.05% | +46.9% |
| Q2 2022 | $641,000 | -19.0% | 12,685 | +2.5% | 0.03% | -11.1% |
| Q1 2022 | $791,000 | -39.9% | 12,376 | +0.7% | 0.04% | -36.8% |
| Q4 2021 | $1,316,000 | -33.6% | 12,291 | -36.2% | 0.06% | -36.7% |
| Q3 2021 | $1,981,000 | +3.0% | 19,267 | -11.9% | 0.09% | +5.9% |
| Q2 2021 | $1,924,000 | +6.5% | 21,868 | +17.7% | 0.08% | +2.4% |
| Q1 2021 | $1,806,000 | +7.8% | 18,576 | +24.3% | 0.08% | 0.0% |
| Q4 2020 | $1,676,000 | -3.0% | 14,946 | -19.8% | 0.08% | -11.7% |
| Q3 2020 | $1,728,000 | +12.5% | 18,645 | -5.3% | 0.09% | +13.3% |
| Q2 2020 | $1,536,000 | – | 19,692 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |